Dengue Virus Vaccine
Creative Biolabs is a forward-looking research institute as well as a leading custom service provider in the field of viral vaccine development. With our extensive experience and advanced platform, we have won good reputation among our worldwide customers for successfully accomplishing numerous challenging projects in viral vaccine development services for dengue virus vaccine. We guarantee the finest results for our customers all over the world.
Dengue virus (DENV), belongs to the Flaviviridae Family, is a mosquito-borne single positive-stranded RNA virus, which causes millions of infections each year, with a high morbidity and mortality rates in tropical and subtropical regions. DENV consists of an enveloped virus with a single-stranded, positive-sense RNA genome. DENV has four serotypes (DENV1-4) and the DENV genome is about 10.7 kb and contains a 50methyl guanosine cap, 50untranslated region (UTR), single open reading frame, and a 30UTR. Infections with DENV can cause dengue fever (DF), dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS). DENV vaccine development is a global health priority to prevent DENV infections. There are many DENV vaccines have been developed to avoid the dramatic increase of DENV infection cases.
Fig.1 The Procedure of DENV Vaccine Development.
The DNA Dengue Virus Vaccine
Dengue virus is the most prevalent viral illness in humans, which leads to a series of disease. The DNA dengue virus vaccine has been studied for decades, the data show that DNA vaccination is involved in DNA cloning and plasmid transfection. Dengue virus-related diseases are usually diagnosed by the identification of polymerase chain reaction (PCR) or combined with clinical features and viral DNA detection. Research shows that it is effective for disease prevention in various populations.
The Recombinant Live Attenuated Dengue Virus Vaccine
Most dengue virus vaccine studies have focused on developing live attenuated vaccines. They have demonstrated a number of advantages, such as the ability to mimic the immune responses to natural infections, the induction of T cell activation and B cell lifelong immune memory. Recombinant live attenuated dengue virus vaccines have been applied in many dengue-related disease prevention. Several recombinant live attenuated dengue vaccines have shown that no adverse reactions and high safety in the clinic.
Our Services for Dengue Virus Vaccine
Our platform provides the state-of-art services for any dengue virus vaccine development project. Our scientists specialized in viral vaccine studies will work with you to develop the most appropriate strategy that will offer the most meaningful data for your research.
- One-stop viral vaccine development solution
- Cost-saving discovery strategy
- Mature viral vaccine technology platform
Creative Biolabs is recognized as the world leader for providing viral vaccine development services for years. We have developed efficient protocols for dengue virus vaccine development. If you are interested in our services, please contact us for more details.
All of our products can only be used for research purposes. These vaccine ingredients CANNOT be used directly on humans or animals.
